Anchor Capital Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,960
| Closed | -$477K | – | 241 |
|
2025
Q1 | $477K | Sell |
1,960
-95,247
| -98% | -$23.2M | 0.01% | 205 |
|
2024
Q4 | $31.9M | Sell |
97,207
-553
| -0.6% | -$182K | 0.91% | 47 |
|
2024
Q3 | $32.7M | Buy |
97,760
+12,190
| +14% | +$4.08M | 0.87% | 49 |
|
2024
Q2 | $23.4M | Sell |
85,570
-14,461
| -14% | -$3.95M | 0.66% | 56 |
|
2024
Q1 | $34.6M | Buy |
100,031
+23,333
| +30% | +$8.07M | 0.91% | 48 |
|
2023
Q4 | $24.8M | Sell |
76,698
-20,844
| -21% | -$6.73M | 0.65% | 55 |
|
2023
Q3 | $35M | Buy |
97,542
+24,889
| +34% | +$8.92M | 0.98% | 42 |
|
2023
Q2 | $27.5M | Buy |
+72,653
| New | +$27.5M | 0.71% | 50 |
|